Literature DB >> 25340203

Effect of non-surgical periodontal treatment on short chain fatty acid levels in gingival crevicular fluid of patients with generalized aggressive periodontitis.

R Lu, H Meng, X Gao, L Xu, X Feng.   

Abstract

BACKGROUND AND
OBJECTIVE: Short chain fatty acids (SCFAs) play important roles in periodontal diseases. However, the concentrations of SCFAs in gingival crevicular fluid of patients with aggressive periodontitis are not known. The aim of this intervention study was to investigate the influences of non-surgical periodontal therapy on levels of SCFAs in the gingival crevicular fluid of patients with generalized aggressive periodontitis (G-AgP), and analyze the concentrations of SCFAs in sites with or without the detected putative periodontal pathogens.
MATERIAL AND METHODS: Eighty gingival crevicular fluid samples (four per subject) were collected on filter paper strips from patients with G-AgP (n = 20; mean age 24.5 years), before and at 2 wk, 2, 4 and 6 mo after non-surgical periodontal treatment. Eighty gingival crevicular fluid samples (four per subject) were collected from periodontally healthy controls (n = 20; mean age 26.2 years). Concentrations of formic acid, succinic acid, acetic acid, lactic acid, propionic acid, butyric acid and isovaleric acid from the supernatant of gingival crevicular fluid samples were measured by high performance capillary electrophoresis. Porphyromonas gingivalis, Treponema denticola, Aggregatibacter actinomycetemcomitans, Prevotella intermedia and Fusobacterium nucleatum from the precipitate of the same pretreatment samples of gingival crevicular fluids were analyzed by polymerase chain reaction amplification.
RESULTS: The clinical parameters of patients with G-AgP during the 6 mo after non-surgical periodontal treatment were improved remarkably. The formic acid concentration increased significantly after treatment; the level of formic acid was lower in the P. gingivalis-, T. denticola-, P. intermedia- or F. nucleatum-positive sites compared with the negative sites. The concentrations of acetic acid, propionic acid and butyric acid reduced significantly after treatment and reached the lowest level at 2 wk post-treatment, although showed a tendency to increase after 2 mo post-treatment, and the three SCFA levels were significantly higher in P. gingivalis-, T. denticola-, P. intermedia- or F. nucleatum-positive sites compared with those in the negative sites.
CONCLUSION: Non-surgical periodontal treatment resulted in a significant decrease of acetic acid, propionic acid, butyric acid levels and increase of formic acid level in gingival crevicular fluids in patients with G-AgP, accompanied by improvement in clinical parameters. A marked lower level of formic acid, as well as higher levels of acetic acid, propionic acid and butyric acid in gingival crevicular fluid of patients with G-AgP was consistent with periodontal pathogen infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25340203     DOI: 10.1111/jre.12137

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  17 in total

1.  Short-chain fatty acids inhibit the biofilm formation of Streptococcus gordonii through negative regulation of competence-stimulating peptide signaling pathway.

Authors:  Taehwan Park; Jintaek Im; A Reum Kim; Dongwook Lee; Sungho Jeong; Cheol-Heui Yun; Seung Hyun Han
Journal:  J Microbiol       Date:  2021-12-04       Impact factor: 3.422

2.  Using NMR in saliva to identify possible biomarkers of glioblastoma and chronic periodontitis.

Authors:  Alberto García-Villaescusa; José Manuel Morales-Tatay; Daniel Monleón-Salvadó; José Manuel González-Darder; Carlos Bellot-Arcis; José María Montiel-Company; José Manuel Almerich-Silla
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

Review 3.  Importance of Virulence Factors for the Persistence of Oral Bacteria in the Inflamed Gingival Crevice and in the Pathogenesis of Periodontal Disease.

Authors:  Gunnar Dahlen; Amina Basic; Johan Bylund
Journal:  J Clin Med       Date:  2019-08-29       Impact factor: 4.241

Review 4.  Distal Consequences of Oral Inflammation.

Authors:  Joanne E Konkel; Conor O'Boyle; Siddharth Krishnan
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

5.  Periodontitis-level butyrate-induced ferroptosis in periodontal ligament fibroblasts by activation of ferritinophagy.

Authors:  Yunhe Zhao; Jiao Li; Wei Guo; Houxuan Li; Lang Lei
Journal:  Cell Death Discov       Date:  2020-11-10

6.  Vikodak--A Modular Framework for Inferring Functional Potential of Microbial Communities from 16S Metagenomic Datasets.

Authors:  Sunil Nagpal; Mohammed Monzoorul Haque; Sharmila S Mande
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

7.  Comparison of the short-chain fatty acids in normal rat faeces after the treatment of Euphorbia kansui, a traditional Chinese medicine for edoema.

Authors:  Dongjing Jiang; Sijia Guo; An Kang; Yonghui Ju; Jingxian Li; Sheng Yu; Beihua Bao; Yudan Cao; Yuping Tang; Li Zhang; Weifeng Yao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

Review 8.  Therapeutic potentials and modulatory mechanisms of fatty acids in bone.

Authors:  Minyue Bao; Kaiwen Zhang; Yangyini Wei; Weihan Hua; Yanzi Gao; Xin Li; Ling Ye
Journal:  Cell Prolif       Date:  2019-12-04       Impact factor: 6.831

9.  Butyrate Decreases ICAM-1 Expression in Human Oral Squamous Cell Carcinoma Cells.

Authors:  Gabriel Leonardo Magrin; Francesca Di Summa; Franz-Josef Strauss; Layla Panahipour; Michael Mildner; Cesar Augusto Magalhães Benfatti; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2020-02-29       Impact factor: 6.208

10.  Effects of Short-Chain Fatty Acids on Human Oral Epithelial Cells and the Potential Impact on Periodontal Disease: A Systematic Review of In Vitro Studies.

Authors:  Gabriel Leonardo Magrin; Franz Josef Strauss; Cesar Augusto Magalhães Benfatti; Lucianne Cople Maia; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.